retatrutide ly3437943 phase 2 trial obesity nejm 2023 Another Promising Medication (Retatrutide) for Phase 3 Trial of Semaglutide

Therapie, 75 (6), 641647

The slowing of gastric emptying and intestinal transitwhilst beneficial for glycaemic control and satietycan lead to harder stools and straining during bowel movements

As glycemic control improves and glucose levels normalize, this effect should actually decrease

Patients were administered exenatide for 48 weeks, followed by a 12-week washout period

With side effects including bowel obstructions, gallstones, and the paralysis of the stomach muscles, Ozempic is far from an easy fix for service-related conditions like Type II diabetes and obesity

Trulicity also uses single-dose pens that you'll discard after each injection